Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI...

|About: Valeant Pharmaceuticals I... (VRX)|By:, SA News Editor

Valeant Pharmaceuticals (VRX +0.1%) and DepoMed (DEPO +3.0%) sue Watson Pharmaceuticals (WPI +0.2%) over its generic glumetza diabetes drug, according to reports. Sales of Glumetza are tipped to reach more than $100M this year.